Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RAS p21 protein activator 4D, pseudogene (RASA4DP) is a non-coding pseudogene related to the RASA4 gene, belonging to the GAP1 family of GTPase-activating proteins. Unlike the protein-coding parental gene and other family members, RASA4DP does not produce a functional protein, has no demonstrated biological activity, and is not implicated in disease or therapeutic targeting[3]. The related gene RASA4 encodes a calcium-activated Ras GTPase-activating protein involved in downregulating the Ras-MAPK signaling pathway, which regulates cell growth and differentiation[4]. However, the pseudogene RASA4DP lacks such function, making it irrelevant as a receptor, drug target, or disease biomarker. If you are seeking information about a functional therapeutic target, you likely want RAS p21 protein activator 4 (RASA4), not "RASA4DP," which is a non-functional pseudogene[3][4].
None
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RAS p21 protein activator 4D, pseudogene (RASA4DP).